Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2006 | 09-2006 | 06-2006 | 03-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,189,957 | 475,690 | 527,854 | 262,704 | 813,914 |
| Depreciation Amortization | 47,284 | 35,517 | 23,833 | 11,243 | 35,777 |
| Income taxes - deferred | -9,220 | -271 | -13,344 | -626 | -53,239 |
| Accounts receivable | -184,370 | -177,570 | -82,961 | -41,329 | 13,753 |
| Accounts payable and accrued liabilities | 263,965 | 136,880 | 82,909 | -874 | 23,356 |
| Other Working Capital | -286,169 | 62,792 | -155,526 | -62,269 | -253,407 |
| Other Operating Activity | 2,576,526 | 205,513 | 105,028 | 53,045 | 125,488 |
| Operating Cash Flow | $1,218,059 | $738,551 | $487,793 | $221,894 | $705,642 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,110,698 | -1,039,014 | -824,893 | -675,736 | -634,527 |
| PPE Investments | -105,208 | -74,995 | -33,584 | -14,258 | -47,951 |
| Net Acquisitions | -2,736,172 | -356,167 | N/A | N/A | N/A |
| Purchase Of Investment | -8,652 | -31,688 | -56,244 | N/A | N/A |
| Investing Cash Flow | $-1,739,334 | $-1,501,864 | $-914,721 | $-689,994 | $-682,478 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,276,242 | 1,276,242 | 1,276,242 | N/A | 298,816 |
| Debt Repayment | -580,684 | -540,563 | -480,421 | -56,132 | -203 |
| Common Stock Issued | 403,386 | 359,319 | 313,399 | 43,529 | 143,283 |
| Common Stock Repurchased | -544,942 | -544,943 | -544,943 | N/A | N/A |
| Other Financing Activity | 95,259 | 79,779 | 50,499 | 37,380 | 0 |
| Financing Cash Flow | $649,261 | $629,834 | $614,776 | $24,777 | $441,896 |
| Exchange Rate Effect | -19,892 | -14,854 | -11,312 | 4,087 | -38,056 |
| Beginning Cash Position | 707,913 | 707,913 | 707,913 | 707,913 | 280,909 |
| End Cash Position | 816,007 | 559,580 | 884,449 | 268,677 | 707,913 |
| Net Cash Flow | $108,094 | $-148,333 | $176,536 | $-439,236 | $427,004 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,218,059 | 738,551 | 487,793 | 221,894 | 705,642 |
| Capital Expenditure | -105,208 | -74,995 | -33,584 | -14,258 | -47,951 |
| Free Cash Flow | 1,112,851 | 663,556 | 454,209 | 207,636 | 657,691 |